Western blotting was performed to evaluate the protein levels of cancer stem cell markers (CD133, Nanog, Oct 4, Sox 2, and ALDH1), which displayed a significant increased after KCNMB2-AS1 overexpression (Figure 2(h)). This evidence concerns the gene ALDH1A1 and cancer.